Alerts will be sent to your verified email
Verify Email
AMBALALSA
|
Ambalal Sarabhai Ent
|
Balaxi Pharma.
|
Alpa Lab
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
19.11 % | 27.3 % | 8.11 % |
|
5yr Avg Net Profit Margin
|
10.89 % | 11.03 % | 10.22 % |
|
Price to Book
|
1.71 | 1.09 | 1.18 |
|
P/E
|
18.65 | 13.39 | 7.7 |
|
5yr Avg Cash Conversion Cycle
|
-37.53 Days | 154.28 Days | 119.67 Days |
|
5yr Average Interest Coverage Ratio
|
9.88 | 57.05 | 75.25 |
|
5yr Avg ROCE
|
24.01 % | 36.52 % | 10.84 % |
|
5yr Avg Operating Profit Margin
|
5.29 % | 16.64 % | 7.49 % |
|
5 yr average Debt to Equity
|
0.32 | 0.09 | 0.02 |
|
5yr CAGR Net Profit
|
-30.01 % | -5.76 % | 55.43 % |
|
5yr Average Return on Assets
|
8.69 % | 18.47 % | 6.5 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
31.35 % | 65.99 % | 57.29 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.59 % | -6.87 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Ambalal Sarabhai Ent
|
Balaxi Pharma.
|
Alpa Lab
|
|---|